Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes

Diabetes

Volumn 52, Issue 6, 2003, Pages 1393-1402

  Højlund, Kurt ^a,e   Stæhr, Peter ^a   Hansen, Bo Falck ^b   Green, Kevin A ^c   Hardie, D Grahame ^c   Richter, Erik A ^d   Beck Nielsen, Henning ^a   Wojtaszewski, Jørgen F P ^d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; INSULIN; PROTEIN KINASE B;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME INACTIVATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE TISSUE; BINDING SITES; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; GLYCOGEN SYNTHASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERINSULINISM; INFUSIONS, INTRAVENOUS; INSULIN; LIPIDS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; REFERENCE VALUES;

EID: 0038321327     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.6.1393     Document Type: Article

References (57)

1. Beck-Nielsen H: Mechanisms of insulin resistance in non-oxidative glucose metabolism: the role of glycogen synthase. J Basic Clin Physiol Pharmacol 9:255-279, 1998
2. Danisbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239-245, 1991
3. Kelley DE, Mandarino LJ: Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 86:1999-2007, 1990
4. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
5. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR: Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85:522-529, 1990
6. Henry RR, Cieraldi TP, Abraham-Carter L, Mudaliar S, Park KS, Nikoulina SE: Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. J Clin Invest 98:1231-1236, 1996
7. Gaster M, Petersen I, Højlund K, Poulsen P, Beck-Nielsen H: The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51:921-927, 2002
8. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
9. Schalin-Jantti C, Harkonen M, Groop LC: Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598-604, 1992
10. Lawrence JC, Jr., Roach PJ: New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46:541-547, 1997
11. Villar PC, Guinovart JJ: The role of glucose 6-phosphate in the control of glycogen synthase. FASEB J 11:544-558, 1997
12. Cohen P, Alessi DR, Cross DA: PDK1, one of the missing links in insulin signal transduction? FEBS Lett 410:3-10, 1997
13. 2- and COOH-terminal phosphorylation sites. Diabetes 49:1096-1100, 2000
14. Skurat AV, Wang Y, Roach PJ: Rabbit skeletal muscle glycogen synthase expressed in COS cells: identification of regulatory phosphorylation sites. J Biol Chem 269:25534-25542, 1994
15. Skurat AV, Roach PJ: Phosphorylation of sites 3a and 3b (Ser640 and Ser644) in the control of rabbit muscle glycogen synthase. J Biol Chem 270:12491-12497, 1995
16. Parker PJ, Caudwell FB, Cohen P: Glycogen synthase from rabbit skeletal muscle: effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur J Biochem 130:227-234, 1983
17. Lawrence JC, Jr., Zhang J: Control of glycogen synthase and phopshorylase by amylin in rat skeletal muscle. J Biol Chem 269:11595-11600, 1994
18. Lawrence JC, Jr., Hiken JF, DePaoli-Roach AA, Roach PJ: Hormonal control of glycogen synthase in rat hemidiaphragms. J Biol Chem 258:10710-10719, 1983
19. Carling D, Hardie DG: The substrate and sequence specificity of the AMP-activated protein kinase: phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1012:81-86, 1989
20. Ahmad Z, Lee FT, DePaoli-Roach A, Roach PJ: Phosphorylation of glycogen synthase by the Ca2+- and phospholipid-activated protein kinase (protein kinase C). J Biol Chem 259:8743-8747, 1984
21. Naldelny S, Campbell DG, Cohen P: The molecular mechanism by which adrenalin inhibits glycogen synthesis. Eur J Biochem 199:713-722, 1991
22. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789, 1995
23. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49:263-271, 2000
24. Wojtaszewski JFP, Hansen BF, Gade J, Kiens B, Markuns JF, Goodyear LJ, Richter EA: Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 49:325-331, 2000
25. Hother-Nielsen O, Henriksen JE, Holst JJ, Beck-Nielsen H: Effects of insulin on glucose turnover in vivo: isotope dilution versus constant specific activity technique. Metabolism 45:82-91, 1996
26. Frayn KN: Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628-634, 1983
27. Højlund K, Wildner-Christensen M, Eshøj O, Skjærbæk C, Holst JJ, Koldkjær O, Jensen DM, Beck-Nielsen H: Reference intervals for glucose, beta-cell polypeptides and counterregulatory factors during prolonged fasting. Am J Physiol Endocrinol Metab 280:E50-E58, 2001
28. Markuns JF, Wojtaszewski JFP, Goodyear LJ: Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle. J Biol Chem 274:24896-24900, 1999
29. Thomas JA, Schlender KK, Larner J: A rapid filter paper assay for UDP glucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25:486-499, 1968
30. Richter EA, Mikines KJ, Galbo H, Kiens B: Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol 66:876-885, 1989
31. Wojtaszewski JFP, Hansen BF, Kiens B, Richter EA: Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes 46:1775-1781, 1997
32. Frame S, Cohen P, Biondi RM: A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7:1321-1327, 2001
33. Sugden C, Crawford RM, Halford NG, Hardie DG: Regulation of spinach SNFl-related (SnRK1) kinases by protein kinases and phosphatases is associated with phosphorylation of the T loop and is regulated by 5′-AMP. Plant J 19:1-7, 1999
34. Caudwell B, Antoniw JF, Cohen P: Calsequestrin, myosin, and the components of the protein-glycogen complex in rabbit skeletal muscle. Eur J Biochem 86:511-518, 1978
35. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG: Characterization of the AMP-activated protein kinase kinase from rat liver, and identification of threonine-172 as the major site at which it phosphorylates and activates AMP-activated protein kinase. J Biol Chem 271:27879-27887, 1996
36. Cohen P, Alemany S, Hemmings BA, Resink TJ, Strålfors P, Lim TH: Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol 159:390-408, 1988
37. Wojtaszewski JFP, Nielsen P, Kiens B, Richter EA: Regulation of glycogen synthase kinase-3 in human skeletal muscle: effects of food intake and bicycle exercise. Diabetes 50:265-269, 2001
38. Flotow H, Roach PJ: Synergistic phosphorylation of rabbit muscle glycogen synthase by cyclic AMP-dependent protein kinase and casein kinase I: implications for hormonal regulation of glycogen synthase. J Biol Chem 264:9126-9128, 1989
39. Chen Z, Heierhorst J, Mann RJ, Mitchelhill KI, Michell BJ, Witters LA, Lynch GS, Kemp BE, Stapleton D: Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett 460:343-348, 1999
40. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105:311-320, 2000
41. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB: Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104:733-741, 1999
42. Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH: Insulin signaling in skeletal muscle of subjects with and without type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45:813-822, 2002
43. Storgaard H, Song XM, Jensen CB, Madsbad S, Bjornholm M, Vaag A, Zierath JR: Insulin signal transduction in skeletal muscle from glucoseintolerant relatives of type 2 diabetic patients. Diabetes 50:2770-2778, 2001
44. Pratipanawatr W, Pratipanawatr T, Cusi K, Berria R, Adams JM, Jenkinson CP, Maezono K, DeFronzo RA, Mandarino LJ: Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Diabetes 50:2572-2578, 2001
45. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
46. Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR: Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidyhnositol 3-kinase activation. J Clin Endocrinol Metab 86:4307-4314, 2001
47. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H: Insulinstimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47:1281-1286, 1998
48. Pratipanawatr T, Cusi K, Ngo P, Pratipanawatr W, Mandarino LJ, DeFronzo RA: Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. Diabetes 51:462-468, 2002
49. Winder WW, Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277:E1-E10, 1999
50. Schmitz-Peiffer C: Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann N Y Acad Sci 967:146-157, 2002
51. Wojtaszewski JFP, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA: Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51:284-292, 2002
52. Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, Goodyear LJ: AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50:921-927, 2001
53. Avignon A, Yamada K, Zhou X, Spencer B, Cardona O, Saba-Siddique S, Galloway L, Standaert ML, Farese RV: Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats: a mechanism for inhibiting glycogen synthesis. Diabetes 45:1396-1404, 1996
54. Lin Y, Brady MJ, Wolanske K, Holbert R, Ruderman NB, Yaney GC: Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle. Am J Physiol Endocrinol Metab 283:E318-E325, 2002
55. Dent P, Lavoinne A, Nakielny S, Caudwell BF, Watt P, Cohen P: The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348:302-308, 1990
56. Suzuki Y, Lanner C, Kim J-H, Vilardo PG, Zhang H, Jie Jang J, Cooper LD, Steel M, Kennedy A, Bock C, Scrimgeour A, Lawrence JC Jr, DePaoli-Roach AA: Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. Mol Cell Biol 21:2683-2694, 2001
57. Walker KS, Watt PW, Cohen P: Phosphorylation of the skeletal muscle glycogen-targetting subunit of protein phosphatase 1 in response to adrenaline in vivo. FEBS Lett 466:121-124, 2000